Region
Featured experience
Tokyo Metro privatization and ¥348.6 billion IPO
The deal is the largest Japanese IPO since 2018
Guotai Junan merger with Haitong and concurrent placement of shares
We advised Guotai Junan Securities on the transaction, creating the largest securities company in China
SP Group Treasury GMTN update and $700 million notes offering
The notes are due 2029
Chagee $411.2 million IPO
We advised Chagee on its IPO and Nasdaq listing
Chindata Group Holdings $300 million notes offering
The high-yield notes are due 2026
CStone Pharmaceuticals HK$392.9 million placing of new shares
We advised CStone Pharmaceuticals on the placement
iQIYI $442 million follow-on offering
We advised the issuer on a follow-on offering of ADSs
Sun Pharmaceutical acquisition of Concert Pharmaceuticals
We advised Sun Pharmaceutical on the transaction
New Horizon Health HK$781.7 million top-up placement of shares
We advised New Horizon Health on the top-up placement
Jinxin Fertility Group HK$1.17 billion top-up placement of shares
The shares are listed on the Hong Kong Stock Exchange
Sunny Optical Technology $400 million sustainability-linked bonds offering
The 5.95% bonds are due 2026
China Resources Beer RMB12.3 billion acquisition of Jinsha Winery
We advised China Resources Beer on the acquisition of a controlling interest in Jinsha Winery
SMFG $5.8 billion senior notes offering
We advised SMFG on its offering of TLAC notes
Bilibili convertible notes exchange and concurrent follow-on equity offering
The transaction involved a convertible notes exchange and a concurrent follow-on offering of ADSs